[1]蒙荫杰,邱华,黄鹏,等.白花香莲解毒颗粒治疗HBeAg阳性慢性乙型肝炎的临床疗效及对血浆外泌体miR-122表达的影响[J].西部中医药,2023,36(06):110-112.[doi:10.12174/j.issn.2096-9600.2023.06.26]
　MENG Yinjie,QIU Hua,HUANG Peng,et al.Clinical Effects of Baihua Xianglian Detoxification Granules in the Treatment of Positive HBeAg Chronic Hepatitis B and Its Influence on Plasma Exosomal miR-122 Expressions[J].Western Journal of Traditional Chinese Medicine,2023,36(06):110-112.[doi:10.12174/j.issn.2096-9600.2023.06.26]
点击复制

白花香莲解毒颗粒治疗HBeAg阳性慢性乙型肝炎的临床疗效及对血浆外泌体miR-122表达的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年06期
页码:
110-112
栏目:
出版日期:
2023-06-15

文章信息/Info

Title:
Clinical Effects of Baihua Xianglian Detoxification Granules in the Treatment of Positive HBeAg Chronic Hepatitis B and Its Influence on Plasma Exosomal miR-122 Expressions
作者:
蒙荫杰1, 邱华2, 黄鹏1, 李旺1, 毛德文2
1.广西中医药大学，广西 南宁 530001
2.广西中医药大学第一附属医院，广西 南宁 530023
Author(s):
MENG Yinjie1, QIU Hua2, HUANG Peng1, LI Wang1, MAO Dewen2
1.Guangxi University of Chinese Medicine, Nanning 530001, China
2.The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, China
关键词:
肝炎; 慢性; 乙型; 乙肝病毒e抗原; 壮医药; 白花香莲解毒颗粒; 外泌体; miR-122
Keywords:
hepatitis;  chronic;  B; HBeAg; medicine; detoxification granules; exosomes; miR-122
分类号:
R512.6
DOI:
10.12174/j.issn.2096-9600.2023.06.26
文献标志码:
B
摘要:
目的观察壮药白花香莲解毒颗粒治疗HBeAg阳性慢性乙型肝炎的临床疗效及对血浆外泌体miR-122表达的影响。 方法将120例HBeAg阳性的慢性乙型肝炎患者随机分为两组，对照组60例给予恩替卡韦治疗，观察组60例给予恩替卡韦联合白花香莲解毒颗粒治疗，两组均治疗48周，同时选取健康体检者30例作为健康组。观察治疗前后两组临床疗效、乙肝两对半定量、血浆外泌体miR-122、乙肝病毒脱氧核糖核酸（HBV DNA）的水平、肝功能及不良反应事件发生情况。 结果治疗48周，观察组总有效率［90%（54/60）］明显高于对照组［71.67%（43/60）］（P＜0.05）。治疗12、24、48周时，两组HBeAg滴度、血清丙氨酸氨基转移酶水平逐渐下降，且观察组显著低于对照组（P＜0.05）；观察组血浆中miR-122相对表达量高于治疗前（P＜0.05），对照组血浆中miR-122相对表达量与治疗前比较，差异无统计学意义（P＞0.05）。治疗12、24、48周时，两组血清HBV-DNA水平逐渐下降（P＜0.05）；观察组治疗12、24周时HBV-DNA水平低于对照组（P＜0.05），但治疗48周后，两组HBV-DNA水平比较，差异无统计学意义（P＞0.05）。 结论白花香莲解毒颗粒能够抑制HBV-DNA的复制及HBeAg分泌，改善肝功能，其疗效机制可能与调节血浆外泌体miR-122的表达有关。
Abstract:
ObjectiveTo observe clinical effects of Zhuang medicine Baihua Xianglian detoxification granules in the treatment of positive HBeAg chronic hepatitis B and its influence on plasma exosomal miR-122 expressions. MethodsA total of 120 patients were randomized into two groups, 60 cases of the control group were treated with entecavir, and 60 ones of the observation group with entecavir and Baihua Xianglian detoxification granule, both groups were treated for 48 weeks, meanwhile, 30 cases having physical examination were chosen as the healthy group. To observe clinical effects of both groups, quantitative examination of HBV infection serum markers (HBsAg, HBsAb, HBeAg, HBeAb and HBcAb), plasma exosomal miR-122, the levels of HBV DNA, liver function and the incidences of adverse reaction before and after the treatment. ResultsAfter treating for 48 weeks, total effective rate of the observation group was [90%(54/60)], obviously higher than [71.67%(43/60)] of the control group (P<0.05). After the treatment of 12, 24 and 48 weeks, HBeAg titer and serum alanine aminotrans-ferase decreased gradually in both groups, the observation group was lower than the control group significantly (P<0.05); the relative expression of plasma miR-122 in the observation group was higher than that before the treatment (P<0.05), the difference had no statistical meaning when the relative expression of plasma miR-122 of the control group was compared with that before the treatment (P>0.05). The levels of HBV-DNA reduced gradually in both groups when they were treated for 12, 24 and 48 weeks (P<0.05); the levels of HBV-DNA of the observation group were lower than these of the control group when they were treated for 12 and 24 weeks (P<0.05), while the difference had no statistical meaning in the levels of HBV-DNA after treating for 48 weeks. ConclusionZhuang medicine Baihua Xianglian detoxification granules could inhibit the replication of HBV-DNA and the secretion of HBeAg, improve liver function, and its clinical effects might be related to regulating the expressions of plasma exosomal miR-122.

相似文献/References:

[1]崔毅.益气活血汤治疗慢性盆腔炎64例临床观察[J].西部中医药,2012,25(12):75.
　CUI Yi.Clinical Observation on YiQi HuoXueTang and Activating Blood Decoction in Treating 64 Cases of Chronic Pelvic Inflammatory Disease[J].Western Journal of Traditional Chinese Medicine,2012,25(06):75.
[2]樊斗霜.枳实消痞丸(汤)合丹参饮加减治疗慢性萎缩性胃炎32例[J].西部中医药,2013,26(02):72.
　FAN Doushuang.Modified ZhiShi XiaoPiWan(Prescription) and DanShenYin in Treating 32 Cases of Chronic Atrophic Gastritis[J].Western Journal of Traditional Chinese Medicine,2013,26(06):72.
[3]尤海鹰.制萎煎治疗脾胃虚弱型慢性萎缩性胃炎40例[J].西部中医药,2013,26(03):84.
　YOU Haiying.ZhiWeiJian in Treating 40 Cases of Chronic Atrophic Gastritis of Spleen-stomach Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(06):84.
[4]张建平,刘洁,赵志亮.针灸治疗慢性前列腺炎25例疗效观察[J].西部中医药,2013,26(03):111.
　ZHANG Jianping,LIU Jie,ZHAO Zhiliang.Observation on Acupuncture in Treating 25 Cases of Chronic Prostatitis[J].Western Journal of Traditional Chinese Medicine,2013,26(06):111.
[5]魏国俊,郑恒恒,指导：燕中.损伤胶囊与正骨水治疗慢性软组织损伤疗效比较[J].西部中医药,2013,26(11):8.
　WEI Guojun,ZHENG Hengheng,Director: YAN Zhong.The Difference in Clinical Effects between SunShang Capsule and Bonesetting Liquid in Treating Chronic Soft Tissue Injury[J].Western Journal of Traditional Chinese Medicine,2013,26(06):8.
[6]朱建坤,温晓辉,梁玉杰△.敦煌葆元膏对下丘脑-垂体-肾上腺轴作用的实验研究*[J].西部中医药,2013,26(11):13.
　ZHU Jiankun,WEN Xiaohui,LIANG Yujie.Experimental Study on the Effects of DunHuang BaoYuan Ointment on Hypothalamic-pituitary-adrenal Axis[J].Western Journal of Traditional Chinese Medicine,2013,26(06):13.
[7]孙国荣,景克荣,权亚喜.生脉注射液对慢性心衰患者心功能及其心率变异性的影响[J].西部中医药,2013,26(04):68.
　SUN Guorong,JING Kerong,QUAN Yaxi.The Influence of ShengMai Injection on Heart Function and Heart Rate Variability of Patients with Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2013,26(06):68.
[8]俄静,夏小军,杨楠.益气温阳法治疗慢性血小板减少性紫癜经验举隅[J].西部中医药,2013,26(06):58.
　E Jing,XIA Xiaojun,YANG Nan.Invigorating Qi and Yang Method in Treating Chronic Thrombocytopenic Purpura[J].Western Journal of Traditional Chinese Medicine,2013,26(06):58.
[9]马继利.中西药物联用治疗慢性萎缩性胃炎58例[J].西部中医药,2013,26(06):91.
　MA Jili.Treatment for 58 Cases of Chronic Atrophic Gastritis with Integrative Medicines[J].Western Journal of Traditional Chinese Medicine,2013,26(06):91.
[10]王富国,张之舜,丁芬.中西医结合治疗慢性阻塞性肺疾病急性加重期28例疗效观察[J].西部中医药,2012,25(09):70.
　WANG Fu-guo,ZHANG Zhi-shun,DING Fen.Treating 28 Cases of Chronic Obstructive Pulmonary Disease at Acute Exacerbation with Integrated Traditional Chinese and Western Medicine[J].Western Journal of Traditional Chinese Medicine,2012,25(06):70.
[11]延保国.还原型谷胱甘肽联合苦黄注射液治疗慢性乙型肝炎40例疗效观察[J].西部中医药,2012,25(09):68.
　YAN Bao-guo.Curative Observation on Reduced Glutathione for Injection and KuHuang Injection in Treating 40 Cases of Chronic Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2012,25(06):68.
[12]叶佩燕,苗慧,杨宗国,等.解毒逐瘀方保留灌肠治疗早中期慢性重型肝炎患者的临床观察[J].西部中医药,2012,25(07):1.
　YE Pei-yan,MIAO Hui,YANG Zong-guo,et al.Clinical Observation on Chronic Severe Hepatitis at Early-Middle Stage Treated with Retention Enema of JieDu ZhuYuFang[J].Western Journal of Traditional Chinese Medicine,2012,25(06):1.
[13]于晨媛.茵陈蒿汤加味联合西药治疗慢性丙型肝炎65例[J].西部中医药,2013,26(09):82.
　YU Chenyuan.Modified YinChenHao Tang Combined with Western Medicine for 65 Cases of Chronic Hepatitis C[J].Western Journal of Traditional Chinese Medicine,2013,26(06):82.
[14]何晶,袁征,陆原,等.基于数据挖掘探讨周珉教授治疗慢性乙型肝炎的用药规律及经验[J].西部中医药,2021,34(06):81.[doi:10.12174/j.issn.2096-9600.2021.06.19]
　HE Jing,YUAN Zheng,LU Yuan,et al.Professor Zhou Min′s Medication Rules and Experience of Treating Chronic Hepatitis B Based on Data Mining[J].Western Journal of Traditional Chinese Medicine,2021,34(06):81.[doi:10.12174/j.issn.2096-9600.2021.06.19]
[15]陈泽山,朱文琳,陈柏尧,等.从湿热中阻论治慢性乙型肝炎研究进展[J].西部中医药,2023,36(02):133.[doi:10.12174/j.issn.2096-9600.2023.02.31]
　CHEN Zeshan,ZHU Wenlin,CHEN Baiyao,et al.Research Progress of Treatment of Chronic Hepatitis B from Damp-heat Obstructing the Middle Energizer[J].Western Journal of Traditional Chinese Medicine,2023,36(06):133.[doi:10.12174/j.issn.2096-9600.2023.02.31]
[16]李彦波,吕文良,强睿,等.吕文良教授“火候”学理论治疗慢性乙型病毒性肝炎[J].西部中医药,2024,37(04):42.[doi:10.12174/j.issn.2096-9600.2024.04.09]
　LI Yanbo,LYU Wenliang,QIANG Rui,et al.Professor Lyu Wenliang′s "Fire" Theory in the Treatment of Chronic Viral Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2024,37(06):42.[doi:10.12174/j.issn.2096-9600.2024.04.09]

备注/Memo

备注/Memo:
蒙荫杰（1993—），男，硕士研究生。研究方向：慢性乙型病毒性肝炎的中医药（壮医药）防治。国家自然科学基金（81860889，81660827）；中国博士后科学基金面上资助项目（2019M653312）；第二批广西高层次骨干人才培养139计划（桂卫科教发［2018］22号）；广西重点研发计划项目（2017AB45166）；广西中医药大学一流学科课题（2019XK020）。
更新日期/Last Update: 2023-06-15